Sprint Bioscience AB banner
S

Sprint Bioscience AB
F:5JA1

Watchlist Manager
Sprint Bioscience AB
F:5JA1
Watchlist
Price: 0.304 EUR 1.67%
Market Cap: €21.2m

Wall St Price Targets

5JA1 Price Targets Summary
Sprint Bioscience AB

Wall Street analysts forecast 5JA1 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.048 EUR with a low forecast of 0.048 EUR and a high forecast of 0.049 EUR.

Lowest Forecast
Price Target
0.048 EUR
84% Downside
Average Forecast
Price Target
0.048 EUR
84% Downside
Highest Forecast
Price Target
0.049 EUR
84% Downside
Sprint Bioscience AB Competitors:
Price Targets
WOOF
Petco Health and Wellness Company Inc
31% Upside
NNOX
Nano-X Imaging Ltd
285% Upside
HCAT
Health Catalyst Inc
26% Upside

Revenue
Forecast

43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.

Operating Income
Forecast

N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate for Operating Income over the next 3 years is -73%.

Net Income
Forecast

N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-69%
Average Miss
N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-69%
Average Miss

The compound annual growth rate for Net Income over the next 2 years is -24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5JA1's stock price target?
Price Target
0.048 EUR

According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.048 EUR with a low forecast of 0.048 EUR and a high forecast of 0.049 EUR.

What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%

Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.

What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%

The compound annual growth rate for Operating Income over the next 3 years is -73%.

What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-24%

The compound annual growth rate for Net Income over the next 2 years is -24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett